Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Noninvasive imaging of renal urea handling by CEST-MRI.

Shin SH, Wendland MF, Zhang B, Tran A, Tang A, Vandsburger MH.

Magn Reson Med. 2020 Mar;83(3):1034-1044. doi: 10.1002/mrm.27968. Epub 2019 Sep 4.

PMID:
31483529
2.

Magnetic Particle Imaging for Highly Sensitive, Quantitative, and Safe in Vivo Gut Bleed Detection in a Murine Model.

Yu EY, Chandrasekharan P, Berzon R, Tay ZW, Zhou XY, Khandhar AP, Ferguson RM, Kemp SJ, Zheng B, Goodwill PW, Wendland MF, Krishnan KM, Behr S, Carter J, Conolly SM.

ACS Nano. 2017 Dec 26;11(12):12067-12076. doi: 10.1021/acsnano.7b04844. Epub 2017 Nov 30.

3.

Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.

van Velthoven CT, Dzietko M, Wendland MF, Derugin N, Faustino J, Heijnen CJ, Ferriero DM, Vexler ZS.

J Neurosci Res. 2017 May;95(5):1225-1236. doi: 10.1002/jnr.23954. Epub 2016 Oct 26.

4.

Diffusion-Weighted Magnetic Resonance Imaging Characterization of White Matter Injury Produced by Axon-Sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.

Talbott JF, Nout-Lomas YS, Wendland MF, Mukherjee P, Huie JR, Hess CP, Mabray MC, Bresnahan JC, Beattie MS.

J Neurotrauma. 2016 May 15;33(10):929-42. doi: 10.1089/neu.2015.4102. Epub 2016 Feb 1.

5.

MRI blood-brain barrier permeability measurements to predict hemorrhagic transformation in a rat model of ischemic stroke.

Hoffmann A, Bredno J, Wendland MF, Derugin N, Hom J, Schuster T, Zimmer C, Su H, Ohara PT, Young WL, Wintermark M.

Transl Stroke Res. 2012 Dec;3(4):508-16. doi: 10.1007/s12975-012-0212-7. Epub 2012 Sep 16.

PMID:
24323835
6.

Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.

Cyran CC, Fu Y, Rogut V, Chaopathomkul B, Wendland MF, Shames DM, Brasch RC.

Acad Radiol. 2013 Oct;20(10):1256-63. doi: 10.1016/j.acra.2013.07.010.

7.

Delayed VEGF treatment enhances angiogenesis and recovery after neonatal focal rodent stroke.

Dzietko M, Derugin N, Wendland MF, Vexler ZS, Ferriero DM.

Transl Stroke Res. 2013 Apr;4(2):189-200. doi: 10.1007/s12975-012-0221-6.

8.

Genetic deletion of CD36 enhances injury after acute neonatal stroke.

Woo MS, Wang X, Faustino JV, Derugin N, Wendland MF, Zhou P, Iadecola C, Vexler ZS.

Ann Neurol. 2012 Dec;72(6):961-70. doi: 10.1002/ana.23727.

9.

Blood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat.

Fernández-López D, Faustino J, Daneman R, Zhou L, Lee SY, Derugin N, Wendland MF, Vexler ZS.

J Neurosci. 2012 Jul 11;32(28):9588-600. doi: 10.1523/JNEUROSCI.5977-11.2012.

10.

Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke.

Faustino JV, Wang X, Johnson CE, Klibanov A, Derugin N, Wendland MF, Vexler ZS.

J Neurosci. 2011 Sep 7;31(36):12992-3001. doi: 10.1523/JNEUROSCI.2102-11.2011.

11.

Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).

Cyran CC, Sennino B, Fu Y, Rogut V, Shames DM, Chaopathomkul B, Wendland MF, McDonald DM, Brasch RC, Raatschen HJ.

Eur J Radiol. 2012 May;81(5):891-6. doi: 10.1016/j.ejrad.2011.07.016. Epub 2011 Sep 1.

12.

MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.

Daldrup-Link HE, Golovko D, Ruffell B, Denardo DG, Castaneda R, Ansari C, Rao J, Tikhomirov GA, Wendland MF, Corot C, Coussens LM.

Clin Cancer Res. 2011 Sep 1;17(17):5695-704. doi: 10.1158/1078-0432.CCR-10-3420. Epub 2011 Jul 26.

13.

Quantitative tissue oxygen measurement in multiple organs using 19F MRI in a rat model.

Liu S, Shah SJ, Wilmes LJ, Feiner J, Kodibagkar VD, Wendland MF, Mason RP, Hylton N, Hopf HW, Rollins MD.

Magn Reson Med. 2011 Dec;66(6):1722-30. doi: 10.1002/mrm.22968. Epub 2011 Jun 17.

14.

Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology.

Hoffmann A, Bredno J, Wendland MF, Derugin N, Hom J, Schuster T, Su H, Ohara PT, Young WL, Wintermark M.

Stroke. 2011 Jul;42(7):2054-60. doi: 10.1161/STROKEAHA.110.597997. Epub 2011 Jun 2.

15.

miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes.

Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D.

J Exp Med. 2011 Mar 14;208(3):549-60. doi: 10.1084/jem.20101547. Epub 2011 Mar 7.

16.

Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities.

Jha P, Golovko D, Bains S, Hostetter D, Meier R, Wendland MF, Daldrup-Link HE.

Cancer Res. 2010 Aug 1;70(15):6109-13. doi: 10.1158/0008-5472.CAN-09-3774. Epub 2010 Jul 14. Review.

17.

Neonatal cerebral hypoxia-ischemia impairs plasticity in rat visual cortex.

Failor S, Nguyen V, Darcy DP, Cang J, Wendland MF, Stryker MP, McQuillen PS.

J Neurosci. 2010 Jan 6;30(1):81-92. doi: 10.1523/JNEUROSCI.5656-08.2010.

18.

Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.

Sennino B, Raatschen HJ, Wendland MF, Fu Y, You WK, Shames DM, McDonald DM, Brasch RC.

Magn Reson Med. 2009 Sep;62(3):616-25. doi: 10.1002/mrm.22040.

19.

Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.

Henning TD, Wendland MF, Golovko D, Sutton EJ, Sennino B, Malek F, Bauer JS, McDonald DM, Daldrup-Link H.

Magn Reson Med. 2009 Aug;62(2):325-32. doi: 10.1002/mrm.22011.

20.

Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.

Cyran CC, Sennino B, Chaopathomkul B, Fu Y, Rogut VS, Shames DM, Wendland MF, McDonald DM, Brasch RC.

Eur Radiol. 2009 Jan;19(1):121-31. doi: 10.1007/s00330-008-1111-x. Epub 2008 Jul 30.

21.

Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.

Cyran CC, Sennino B, Chaopathomkul B, Fu Y, Rogut V, Shames DM, Wendland MF, McDonald DM, Brasch RC.

Invest Radiol. 2008 May;43(5):298-305. doi: 10.1097/RLI.0b013e318164b71d.

22.

Early diffusion-weighted MRI as a predictor of caspase-3 activation after hypoxic-ischemic insult in neonatal rodents.

Wendland MF, Faustino J, West T, Manabat C, Holtzman DM, Vexler ZS.

Stroke. 2008 Jun;39(6):1862-8. doi: 10.1161/STROKEAHA.107.506352. Epub 2008 Apr 17.

23.

Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.

Raatschen HJ, Simon GH, Fu Y, Sennino B, Shames DM, Wendland MF, McDonald DM, Brasch RC.

Radiology. 2008 May;247(2):391-9. doi: 10.1148/radiol.2472070363. Epub 2008 Mar 27.

24.

New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues.

Cyran CC, Fu Y, Raatschen HJ, Rogut V, Chaopathomkul B, Shames DM, Wendland MF, Yeh BM, Brasch RC.

J Magn Reson Imaging. 2008 Mar;27(3):581-9. doi: 10.1002/jmri.21245.

PMID:
18219614
25.

Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.

Fu Y, Raatschen HJ, Nitecki DE, Wendland MF, Novikov V, Fournier LS, Cyran C, Rogut V, Shames DM, Brasch RC.

Biomacromolecules. 2007 May;8(5):1519-29. Epub 2007 Apr 3.

PMID:
17402781
26.

MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent.

Saborowski O, Simon GH, Raatschen HJ, Wendland MF, Fu Y, Henning T, Baehner R, Corot C, Chen MH, Daldrup-Link HE.

Contrast Media Mol Imaging. 2007 Mar-Apr;2(2):72-81.

PMID:
17385788
27.

Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke.

Denker SP, Ji S, Dingman A, Lee SY, Derugin N, Wendland MF, Vexler ZS.

J Neurochem. 2007 Feb;100(4):893-904. Epub 2006 Dec 22.

28.

MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent.

Raatschen HJ, Swain R, Shames DM, Fu Y, Boyd Z, Zierhut ML, Wendland MF, Misselwitz B, Weinmann HJ, Wolf KJ, Brasch RC.

Contrast Media Mol Imaging. 2006 May-Jun;1(3):113-20.

PMID:
17193687
29.
30.

MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.

Simon GH, von Vopelius-Feldt J, Wendland MF, Fu Y, Piontek G, Schlegel J, Chen MH, Daldrup-Link HE.

J Magn Reson Imaging. 2006 May;23(5):720-7.

PMID:
16557494
31.

Aminoguanidine inhibits caspase-3 and calpain activation without affecting microglial activation following neonatal transient cerebral ischemia.

Dingman A, Lee SY, Derugin N, Wendland MF, Vexler ZS.

J Neurochem. 2006 Mar;96(5):1467-79. Epub 2006 Feb 8.

32.

Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol.

Simon GH, von Vopelius-Feldt J, Fu Y, Schlegel J, Pinotek G, Wendland MF, Chen MH, Daldrup-Link HE.

Invest Radiol. 2006 Jan;41(1):45-51.

PMID:
16355039
33.

Magnetic resonance imaging as a surrogate measure for histological sub-chronic endpoint in a neonatal rat stroke model.

Derugin N, Dingman A, Wendland MF, Fox C, Bollen A, Vexler ZS.

Brain Res. 2005 Dec 20;1066(1-2):49-56. Epub 2005 Dec 5.

PMID:
16336947
34.

T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.

Simon GH, Bauer J, Saborovski O, Fu Y, Corot C, Wendland MF, Daldrup-Link HE.

Eur Radiol. 2006 Mar;16(3):738-45. Epub 2005 Nov 25.

PMID:
16308692
35.

Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain.

Saito R, Krauze MT, Bringas JR, Noble C, McKnight TR, Jackson P, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Hong K, Berger MS, Park JW, Bankiewicz KS.

Exp Neurol. 2005 Dec;196(2):381-9. Epub 2005 Sep 28.

PMID:
16197944
36.

Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.

Simon GH, Raatschen HJ, Wendland MF, von Vopelius-Feldt J, Fu Y, Chen MH, Daldrup-Link HE.

Acad Radiol. 2005 Sep;12(9):1190-7.

PMID:
16099684
37.

Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion.

Fox C, Dingman A, Derugin N, Wendland MF, Manabat C, Ji S, Ferriero DM, Vexler ZS.

J Cereb Blood Flow Metab. 2005 Sep;25(9):1138-49. Erratum in: J Cereb Blood Flow Metab. 2006 Mar;26(3):446.

38.
39.

Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging.

Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS.

Cancer Res. 2004 Apr 1;64(7):2572-9.

41.

Contrast-enhanced MR delineation of stunned myocardium with administration of MnCl(2) in rats.

Krombach GA, Saeed M, Higgins CB, Novikov V, Wendland MF.

Radiology. 2004 Jan;230(1):183-90.

PMID:
14695393
42.

Genetic determinants of malignancy in a mouse model for oligodendroglioma.

Weiss WA, Burns MJ, Hackett C, Aldape K, Hill JR, Kuriyama H, Kuriyama N, Milshteyn N, Roberts T, Wendland MF, DePinho R, Israel MA.

Cancer Res. 2003 Apr 1;63(7):1589-95.

43.

The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling.

Watzinger N, Lund GK, Higgins CB, Wendland MF, Weinmann HJ, Saeed M.

J Magn Reson Imaging. 2002 Dec;16(6):633-40.

PMID:
12451576
45.

Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model.

Saeed M, Watzinger N, Krombach GA, Lund GK, Wendland MF, Chujo M, Higgins CB.

Radiology. 2002 Sep;224(3):830-7.

PMID:
12202722
46.

Gd-labeled liposomes for monitoring liposome-encapsulated chemotherapy: quantification of regional uptake in tumor and effect on drug delivery.

Rubesova E, Berger F, Wendland MF, Hong K, Stevens KJ, Gooding CA, Lang P.

Acad Radiol. 2002 Aug;9 Suppl 2:S525-7. No abstract available.

PMID:
12188328
47.

MRI of antigen-induced arthritis in rabbits: improved contrast and disease characterization with the blood pool agent MS-325.

Jiang Y, Zhao JJ, Tang H, Wendland MF, Roberts TP, Lauffer RB, Genant HK.

Acad Radiol. 2002 Aug;9 Suppl 2:S480. No abstract available.

PMID:
12188314
48.

Contrast enhanced MRI of stunned myocardium using Mn-based MRI contrast media.

Wendland MF, Krombach GA, Higgins CB, Novikov V, Saeed M.

Acad Radiol. 2002 Aug;9 Suppl 2:S341-2. No abstract available.

PMID:
12188269
49.

Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?

Brasch RC, Gossmann A, Helbich TH, Kuriyama N, Roberts TP, Shames DM, van Bruggen N, Wendland MF, Israel MA.

Acad Radiol. 2002 Aug;9 Suppl 2:S326-7. No abstract available.

PMID:
12188263
50.

Assessment of myocardial viability using standard extracellular and necrosis specific MR contrast media.

Saeed M, Wendland MF, Bremerich GL, Weinmann HJ, Higgins CB.

Acad Radiol. 2002 May;9 Suppl 1:S84-7. No abstract available.

PMID:
12019905

Supplemental Content

Loading ...
Support Center